Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - BioSphere Medical, Inc. (NasdaqNM:BSMD)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug 20Price hit new 52-week low ($8.75)
Location
1050 Hingham Street
Rockland, MA 02370
Phone: (781) 681-7900
Fax: (781) 681-5093
Email: rpalladi@biospheremed.com
Employees (last reported count): 67
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 40%
·Over the last 6 months:
 · one insider sell; 2.00M shares
  (28.1% of insider shares)
·Institutional: 13% (21% of float)
(25 institutions)
·Net Inst. Buying: 435.0K shares (+21.36%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
BioSphere Medical, Inc. is pioneering the use of its proprietary bioengineered acrylic beads, known as microspheres, for medical applications using embolotherapy techniques and also to develop potential applications in several non-embolotherapy applications. The Company's initial product, Embosphere Microspheres, is intended for use in passive embolotherapy to block the blood supply to hypervascularized tumors and arteriovenous malformations. The Company is also developing HepaSphere SAP Microspheres, which are expandable microspheres for injection via catheter into the blood vessels feeding the liver cancer tumor, through its wholly owned subsidiary, BioSphere Medical Japan, Inc.
More from Market Guide: Expanded Business Description

Financial Summary
BSMD is engaged in the medical device business, focusing on the non-surgical treatment of uterine fibroids. Products are used in embolizing hypervascularized tumors, arteriovenous malformations and hemostasis. For the six months ended 6/30/01, revenues totaled $4.3 million, up from $1.6 million. Net loss rose 32% to $4.8 million. Results reflect the market penetration of the Embosphere Microsphere sales in the U.S., offset by higher product commercialization costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Jean-Marie Vogel, 50
Chairman
$243K$748K
John Carnuccio, 47
Pres, CEO, Director
287K267K
Alain Brunier, 56
Pres, European Operations
--  --  
Robert Palladino, 46
VP, CFO
194K--  
Donald Anderson, 50
VP, U.S. Marketing
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BSMDAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Aug-2001
$8.75 
Recent Price$11.24 
52-Week High
on 31-Jan-2001
$19.813
Beta-0.21 
Daily Volume (3-month avg)84.5K
Daily Volume (10-day avg)52.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-2.3%
52-Week Change
relative to S&P500
+31.1%
Share-Related Items
Market Capitalization$142.9M
Shares Outstanding12.7M
Float7.60M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.02 
Earnings (ttm)-$0.92 
Earnings (mrq)-$0.21 
Sales (ttm)$0.64 
Cash (mrq)$0.89 
Valuation Ratios
Price/Book (mrq)10.97 
Price/EarningsN/A 
Price/Sales (ttm)17.71 
Income Statements
Sales (ttm)$6.63M
EBITDA (ttm)-$9.38M
Income available to common (ttm)-$9.61M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-57.60%
Return on Equity (ttm)-73.69%
Financial Strength
Current Ratio (mrq)3.67 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$9.40M
Short Interest
As of 8-Aug-2001
Shares Short211.0K
Percent of Float2.8%
Shares Short
(Prior Month)
243.0K
Short Ratio3.01 
Daily Volume70.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.